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ABSTRACT  
BACKGROUND: Since 2006 incidence rates of chlamydia (C. trachomatis) have increased in 
the United States to epidemic proportions.  The estimated prevalence is four million people. The 
reported chlamydia infection rate for North Carolina is 524/100,000 compared to the national 
rate of 426/100,000. The NC rates in 2011 for black/ African Americans (B/AA) were 
1073/100,000 in men and 3569/1000 in women less than 25 years old (Center for Disease 
Control and Prevention [CDC], 2011). 
 
OBJECTIVE:  This paper describes the urgent need in North Carolina for increased chlamydia 
prevention strategies and resources specifically for high risk subpopulations like young B/AA 
men and women. 
 
RESEARCH QUESTION:  What additional interventions should be implemented in North 
Carolina to reduce chlamydia infection rates? 
 
STUDY DESIGN:  Textbooks and online sources were consulted for background etiologic 
information and CDC records were examined for 2006-2012 chlamydia prevalence.  Health 
policies were researched using CDC references and individual state websites from a cohort of 
states with similar chlamydia incidence rates similar to those of North Carolina. PubMed, Rand 
Corporation, and Robert Wood Johnson Foundation databases were searched for intervention 
programs. 
 
RESULTS:  Data reviewed for 2012 showed North Carolina had the fourth highest reported 
chlamydia incidence rate in the nation.  The subpopulations of highest chlamydia incidence were 
B/AA male and female less than 25 years old and men who have sex with men (MSM).  
Chlamydia infections and reinfections continue to burden the limits of the healthcare resources. 
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Research continues to implicate co-morbidities of chlamydia and HIV infections emphasizing 
the urgency on two fronts. Public health policies in ten states with high chlamydia were 
compared to NC for improved outcomes. Other states and nations have taken stronger prevention 
and control actions and those steps were analyzed for feasibility in NC. 
  
CONCLUSIONS: Increased screening among men and women under 26 years old could 
decrease chlamydia incidence, in conjunction with existing policies in North Carolina.   
Interventions require improved access and partner management especially among young teens, 
age and gender specific healthy behavior education and increased community involvement 
targeting three high risk groups: minorities, men, and pregnant women (USPTF, 2007). Other 
subgroups with rates higher than the state average include MSM, those with multiple sexual 
partners or recent sexual disease infections, the incarcerated, the homeless and high risk women 
of child bearing age (National Survey of Sexual Health and Behavior, 2010) (Behavior Risk 
Factor Surveillance Survey, 2007) (Stein, 2013) (Brewer, 2012). More frequent screening is 
recommended to contain the disease in the target groups. Physicians, legislators, and insurance 
providers would benefit by working together for new state health policies and funding to expand 
chlamydia screening, linking services with Medicaid or other healthcare insurance providers. 
Increased screening may be linked to established policies or procedures such as pregnancy tests, 
annual physicals, PAP smears, and admittance to correctional institutions and homeless shelters.   
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INTRODUCTION 
Since 1992 the incidence rates for Chlamydia trachomatis have risen from 182/100,000 
to 457/100,000 (Center for Disease Control and Prevention [CDC], 2012). Since 1994 chlamydia 
rates have been higher among sexually transmitted diseases than gonorrhea, syphilis or HIV 
(CDC, 2010). The serious health consequences and economic impact of untreated or multiple 
infections, subsequent to pelvic inflammatory disease (PID) further increases the urgency of 
addressing epidemic levels of a treatable disease.  This research focused on the underestimation 
of high incidence in men, especially men who have sex with men (MSM.) Strategic efforts are 
necessary for additional intervention programs targeting the high risk groups, men and women 
under 26 years old, specifically minorities and men that have sex with men. 
Since 2006, the chlamydia epidemic fails to be widely recognized or sufficiently 
contained as the prevalence rates continue to climb: 1,030,900 cases in 2006; 1,210,500 cases in 
2008; 1,307,900 in 2010; and 1,423,000 in 2012 (CDC, 2010) (Payne, 2012). More intensive 
intervention programs are needed to decrease infections and the resulting sequellae including 
sterility, tubal pregnancy, and higher risk of infection and transmission of chronic viruses like 
hepatitis and HIV. The healthcare industry spends more than an estimated 700 million dollars for 
infertility alone (US Preventative Service Task Force [USPSTF], 2007). Extreme disparity is 
seen particularly among socio-economically disadvantaged young B/ AA people, accounting for 
more than forty percent of chlamydia cases reported (CDC, 2011).  The reported chlamydia 
infection rate for North Carolina is 524/100,000 compared to the national rate of 426/100,000. 
The NC rates in 2011 for B/AA are 1073/100,000 in men and 3569/100,000 in women less than 
25 years old (CDC, 2011).  Accordingly, North Carolina had the fourth highest reported 
chlamydia incidence rates in the US (CDC, 2011). This research advocates for implementing 
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more robust population targeted chlamydia intervention measures in North Carolina and 
throughout the nation. 
RESEARCH PLAN 
The research question for this paper was ‘What additional interventions are needed in 
North Carolina to decrease chlamydia infections?’ Etiologic agent information and identification 
of the subpopulations with the highest incidence rates was collected from epidemiology and 
infectious disease reference textbooks and online sources.  CDC publically accessible data bases 
were examined for 2006-20012 chlamydia prevalence nationally. Public health policies 
regarding sexual health behaviors and chlamydia prevention was examined in a cohort of the ten 
highest incidence states. 
To determine significant risk factors and corresponding interventions, searching 
PubMed’s database with the key words chlamydia, HIV and MSM yielded more than 500 
articles to review.  Many from this query were focused on ocular infections or lymphogranuloma 
venereum in MSM, disease burdens beyond the scope of this study.  Others were out of the date 
range for studies to be considered current information, 2007-2013.  Also excluded were global 
studies of increasing chlamydia infections in sex workers. Summarized risk factors including 
demographics and socio-economics for chlamydia, found to be similar to other STD including 
HIV. 
Ten states with the highest prevalence were selected and their public health policies 
regarding chlamydia prevention programs for comparison to North Carolina’s. Health policies 
were researched using CDC Healthy States Reports for 2009 along with individual state 
websites. Highlights included condom attitudes, partner treatment, and sex education in schools. 
The last area of research entailed components of successful interventions found in states outside 
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the cohort, California, Tennessee, New Mexico and Georgia. Global partners in Thailand, 
Europe, Australia, China and South America gave insight to overcoming screening obstacles.  
 
MAJOR FINDINGS FROM DATA COLLECTION 
 
Background 
The development of effective diagnostic, treatment and control strategies requires 
understanding the etiologic agent and epidemiology. C. trachomatis is a small gram negative 
bacterium.  It is an obligate intracellular parasite; it cannot live or replicate outside a host or 
produce its own energy. 
The developmental stages of chlamydia begin when an epithelial cell contacts the 
elementary body (EB) or the infectious form of chlamydia which has tough outer membrane to 
protect it outside a cell.  As the sheer number of infective EBs released far exceeds the number 
of bacteria reproduced by pathogens such as gonorrhea, the infectivity rate of chlamydia is 
between 25-50% per exposure (Mayer, 2010).  
EB antigens are recognized by host cells that have been previously exposed stimulating 
limited acquired or protective immunity (CDC, 2008). More research is needed to determine if 
this immunity improves natural resolution and self-limiting infections versus inflammation that 
progresses to the fallopian tubes and persists. One theory is that T lymphocyte response 
inactivates extracellular EB’s. As seen in Figure 1 EB’s reorganize and become the living form, 
reticular bodies (RB) which then replicate. Research may one day determine whether the 
inflammation produced by genotyping strains of chlamydia intracellular RB’s distinguish 
virulence and pathogenesis characteristics. In the future, immunobiology research may be helpful 
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in vaccine development. Serology tests are currently available to establish prior or current 
infections (Journal of Infectious Disease, 2010).   
 
 Figure 1 Developmental Cycle of Chlamydia 
 
From Mayer, 2010, Microbiology and immunology on-line, USC School of Medicine. 
 
 
Disease Symptoms and Sequellae 
Chlamydia is often asymptomatic or symptoms develop one to three weeks after contact; 
therefore the Greeks named it chlamydia, derived from the word meaning ‘cloaked or hidden.’  
More than 30% of men and 70-80% of women infected with chlamydia are asymptomatic.  
Infections are transmitted perinatally or by vaginal, oral, and anal sex. 
The genus is divided into three biological variants, biovars, and further divided into 
serological variants or serovars. Mayer gives a clear distinction between various diseases caused 
by the bacteria C. trachomatis. Serovars A-C cause diseases of the eye, referred to as Trachoma. 
Serovars D-K are found with infections of the cervix, urethra, conjunctiva and infant pneumonia 
from perinatal infection. Serovar L is associated with Lymphogranuloma venereum (Mayer, 
2010). This paper is pertaining to serovars D-K which is primarily sexually transmitted.  
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  Men typically present with dysuria, urethritis and a clear or mucoid discharge.  Non-
gonorrheal urethritis is attributed to chlamydia in 40-50% of cases. Funding is not often available 
for confirmation tests in public health or other clinics for low income and underinsured 
populations.  Infections that are not confirmed are not reported to CDC. 
Symptoms in women include a mucoid discharge that may or may not be purulent, 
abdominal pain, cervical friability and edema.  Studies have shown that the lining of the vagina 
is thinner and more fragile than the skin of the penis and in this respect women are more 
susceptible than men. The cervix of young girls is not fully mature and more susceptible to 
infections (CDC, 2009).  If left untreated, an estimated 30% of chlamydia infections will 
progress to pelvic inflammatory disease (PID) characterized by irreversible damage: fibrosis, 
scarring of the fallopian tubes and infertility (Nelson and Williams, 2009). In a 1975 Swedish 
study, Westrom reported 10% of women with one case of PID had tubal infertility, 25% of those 
with two cases of PID, and among those with three cases, 60% also had tubal infertility 
(Westrom, 1975). Pregnant women may also become infected, putting their babies at risk for 
chlamydial conjunctivitis or pneumonia. Subsequent infections increase the risk for more adverse 
outcomes such as birth defects, ectopic pregnancies and chronic pain.   
Chlamydia infections increase the risk for additional bacterial STDs like gonorrhea and 
subsequent or co-morbid viral infections of Hepatitis B, Herpes simplex, and HIV (Chesson, 
2012). By activating the lymphatic immune response in the genital region there is decreased 
resistance to viral exposure. Chlamydia infections also increase HIV disease progression and 
transmission due to increased HIV shedding. “Risk factors for chlamydia concomitant with 
newly diagnosed cases of HIV were found to be 10.6% whereas in established positive HIV 
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cases, 65% were positive for chlamydia in the 15-24 year old B/AA group” (Nelson and 
Williams, 2007).  
 Diagnostic Tests 
Currently the most sensitive and specific diagnostic tests for chlamydia are nucleic acid 
amplification probes (NAAT) and polymerase chain reaction assays (PCR.) Comparing cell 
cultures, the gold standard test, to PCR specificity was 99.7% and 97.7% respectively.  However, 
PCR sensitivity was 92% compared to 73% with cell cultures (Yip, 2008).  Specimen collection 
and handling is less demanding for nucleic acid tests. Viable cells are not necessary for positive 
qualitative results. Positive results may be detected with as few as ten organisms, eliminating 
false negative rates with cell cultures reported as high as 57% (Wang, 2011). 
 
US Prevalence and Factors Determining Health Status 
The US reported chlamydia prevalence rate for 2011 is 472/100,000, an estimated rate of 
chlamydia infections of 1.3 million (CDC, 2010).  This is a 16% increase from 409/100,000 
reported in 2009. For comparison, the rate of gonorrhea was 99/100,000 in 2009 and 
103/100,000 in 2011. From 1999 to 2010 CDC estimates 8% of sexually active females ages 14-
19 years were infected with chlamydia. Confirmed cases are reported to CDC but the actual 
number of cases versus reported statistics could be improved if more people were screened for 
asymptomatic infections and private physicians understood the value of reporting cases. 
Chlamydia cases by gender, age groups and race or ethnicity are listed in Table 1. The 
five races included are white, B/AA, Hispanic, Asian and Pacific Islanders and American Indian 
with Native Alaskans. Disparities between white and minority rates of infection with chlamydia
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Table 1 Chlamydia Rates by Race/Ethnicity, Age Group, and Sex, United States, 2009 
  
White 
  
Black/AA 
  
Hispanic 
Asians/ Pacific Islanders 
American Indians/  
Alaska Natives 
Age Total Male Female Total Male Female Total Male Female Total Male Female Total Male Female 
10-14 21 2 41 281 65 504 60 12 110 11 2 20 85 15 158 
15-19 876 219 1,570 6,765 3,008 10,630 1,866 632 3,175 484 123 868 1,985 647 3,350 
20-24 1,094 492 1,728 6,802 4,056 9,604 2,299 1,078 3,680 785 337 1,254 2,331 1,043 3,663 
25-29 442 272 615 2,798 2,077 3,500 1,022 540 1,623 376 200 50 1,151 537 1,777 
30-34 185 129 242 1,308 1,156 1,447 468 260 721 169 96 239 593 324 866 
35-39 74 60 90 574 598 552 243 142 360 98 67 128 286 137 434 
40-44 36 35 38 286 342 236 128 90 170 66 49 83 143 86 197 
45-54 15 18 13 124 150 100 56 42 70 34 28 40 51 37 64 
55-64 4 6 3 41 51 33 19 14 23 14 11 16 14 11 17 
TOTAL 179 84 270 1,559 970 2,095 504 238 789 149 72 222 324 1,215 1,005 
 
Note from CDC National Overview Population Profile 2009 
**Rates per 100,000  
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have not been resolved by national screening recommendations in place for 20 years (CDC, 
2013).  The incidence in the B/AA population (1600/100,000) was eight times as high as the 
incidence in the white race (200/100,000.) The rate for Hispanics (500/100,000) was 2.5 times 
the rate of whites. The rate for the American Indian/ Alaska Natives (300/100,000) more than 
doubled in 2012 (728/100,000). 
Age categories in Table 1 begin with 10-14 years old. The rate for whites in this young 
group is 21/00,000. Comparing the same age category in the Asian race, only half as many cases 
are reported (11/100,000.) However, higher numbers are seen in the American Indians 
(85/100,000) Hispanics (60/100,000) and the highest among B/AA (281/100,000.)  
The highest rates, from 890/100,000 among whites to 7000/100,000 among B/AA, are in 
the 15-19 years age group of all races except Asians. The Asian rates are higher in the 20-24 year 
old category (785/100,000) compared to 484/100,000 in 15-19 year olds.   
The gaps in sexual health are manifestations of complex combinations of risk factors 
aside from race. In 2003, the World Health Organization (WHO) listed social determinants of 
health beginning with social gradients. The gradient is based on life expectancy and frequency of 
diseases in an inversely proportional relationship.  Some of these risk factors, or the lack of 
social determinants of health, follow racial lines. For example, whites attain four year degrees at 
twice the rate of B/AA and three times more frequently than Hispanics. Chlamydia rates are the 
lowest among Asians and whites, parallel to education and income levels.  
Gender equality is another determinant of health. Reported chlamydia case ratios male to 
female vary disproportionately along racial lines. Ratios of men to women vary from 1:7 in 
whites and Asians to 1:3.5 in B/AA among those 15-19 years old. The highest male to female 
ratio, 1:5, is in the American Indian/ Native Alaskan race (647/100,000 to 3350/100,000.)  In the 
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20-24 age group, male to female ratios are much closer. White males to females were 
492/100,000 to 1728/100,000. Asian men to women were 337/100,000 to 1254/100,000. 
American Indian male to female rates in this category were similar to Hispanics, 1043/100,000 to 
3663/100,000 and 1078/100,000 to 3680/100,000 respectively. In the B/AA the male to female 
ratio was 4056/100,000 to 9604/100,000 or 1:2.4 (CDC, 2009). In the 25-29 year old category 
the ratio for B/AA reverses from female to male predominance 598/100,000 men to 552/100,000 
women. The pattern continues in the B/AA race with increasing age. In the 45-54 year old group 
the male to female ratio is 1.5:1. In all other races female cases outnumber those reported for 
men. Additional factors for disproportionate gender ratios may include underreporting of male 
cases and access for men to healthcare because of employment, incarceration, belief that sickness 
is a sign of weakness or fear of medical exams among men. 
Providers addressing male health have an opportunity to improve the accuracy of male 
cases by routinely screening for chlamydia.  However, policy and funding have not supported 
healthcare for low income men. Currently, the men reported positive for chlamydia are 
predominately those whose partners were tested in family planning or STD clinics (CDC Special 
Focus Profiles, 2009). Symptomatic males are considered presumptively positive without 
confirmatory testing; presumptive cases are not reported to the CDC. Policies are another 
determinant of health listed by the WHO. 
 
North Carolina Statistics 
In Table 2 the rate of chlamydia infections in North Carolina was 524/ 100,000 compared 
to the national rate of 456/100,000 in 2009. The ratio of female to male cases was 5.3. Similar to 
US statistics, the highest rates were in the 15-29 years old groups of minorities. In B/AA 15-24 
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years old the prevalence rates are greater than 5000/100,000, five times the rates of whites in the 
same age group. In the 25-29 year old group B/AA rates are six times the white rate in that age 
bracket. The total number of infections among B/AA is more than 25% of all reported cases. The 
greatest disparity is seen in the rate among female B/AA in the 15-24 age group, 8,512/100,000 
(CDC, 2009). 
 
Table 2 Chlamydia Prevalence Rate per 100,000 in by Age, Gender, Race/ Ethnicity 
North Carolina, 2009 
 
 
 
 
 
 
 
 
 
 
Note from CDC/STD/stats2009, CDC/Healthy States, 2009 
 
 
Lower than average rates were seen among Asian/ Pacific Islanders in all age groups. 
However, the rates for Asians were higher than whites in North Carolina. In the national report 
Asian rates were lower than whites. 
Disparities are also evident in the Alaska Natives/ American Indian population. Rates in 
the 15-19 year old category, 2200/100,000, are three times the 15-19 year old rates for whites 
700/100,000. Only in the American Indian race is the rate higher in the 20-24 year group.  The 
reported infections are more than twice those of whites in the 20-24 and 25-29 year old groups. 
Age Total Male Female White Black/ 
BAA 
Hispanic 
Asian/ 
Pacific 
Islanders 
Am. 
Indians/ 
Alaska 
Natives 
15-19 2,050 774 3,378 722 5,052 1,160 448 2,181 
20-24 2,270 1,187 3,408 882 5,218 1,507 750 1,853 
25-29 911 598 1,236 329 2,054 797 398 666 
30-34 419 309 531 109 893 413 120 386 
35-39 187 153 220 47 
 
358 207 72 90 
Total 4400 700 3700 166 1450 535 189 527 
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NC’s American Indian rates are nearly the same as Hispanic rates, approximately 530/100,000. 
In the national report Hispanic rates, 504/100,000 are higher than American Indian rates, 
324/100,000. 
Among young Hispanics the rates are also higher than for whites. In the 15-19 year old 
group the Hispanic rate, 1200/100,000 was 1.6 times higher than the white rate (700/100,000) 
and in the 20-24 year bracket Hispanic rate (1500/100,000) was 1.7 times higher than the white 
rate (900/100,000.) However, in the next age group, 25-29 years old, the Hispanic rate 
(800/100,000) was 2.4 times higher than 300/100,000 for whites. 
Sexually transmitted diseases are often found in pockets or networks of people with high 
risk sexual behaviors. Syphilis has been under national surveillance in the United States since 
1941 (CDC, 2012). Primary prevention included education about the disease and symptoms as 
well as community awareness of the benefits of condom use. Rates decreased until 2000-2001 
due to extensive screening and dedicated public health efforts to treat patients and their partners. 
By secondary prevention, locating and treating the patients’ partner(s), the cycle of infection and 
reinfection was interrupted.  In 2002, the number of cases reported was 6,862 with a decrease 
among B/AA from 12/100,000 to 10/100,000. Ten years later, the number of cases reported was 
15,667, an 11% increase only among men. The ratio of male to female syphilis cases was 10:1. 
75 % of all primary and secondary stage (P&S) cases were reported among men with a rate of 
9.3/100,000. From 2008-2012 cases among MSM increased 46%. Syphilis also increases the risk 
of transmission of HIV and is often co-morbid with HIV among MSM. In the 2012 report, P&S 
syphilis was highest among B/AA (16/100,000) six times the rate among whites (3/100,000.) The 
disparity between B/AA and whites has reversed from cases predominantly among whites in 
earlier years. The rate among Hispanics (6/100,000) was twice that of whites. Of new cases, 44% 
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were reported in the Southern region. The age group with a 45% increase over five years is 
among those 20-29 years old (CDC, 2012). 
The disparities reported by North Carolina’s Communicable Disease Unit pertaining to 
early detection of primary syphilis are now similar to those seen with infections of chlamydia 
and HIV.  “In 2009, non-Hispanic black males represented 74% of reports for males, while 
reports for non-Hispanic white males decreased to 21%, and reports for Hispanics decreased to 
3%.  While the absolute number of reports has increased for all ethnic male groups in 2009, the 
increases have been substantial for non-Hispanic black males, consistent increases in proportion 
over time” (CDC, 2009).  
 
Risk Factors for Chlamydia Infections 
Risk factors for sexually transmitted diseases are complex and overlap personal 
demographics, personal health behaviors and the social environment creating a constellation of 
direct and indirect factors for increased vulnerability to diseases like chlamydia (CDC, BRFSS, 
2010). The major risk factors are categorized in the next section, Tables 3-7, using an expanded 
ecological model of behavior and social influence that also takes into account biological and the 
environmental factors that determine health. (Shi and Zhong, 2014). In this system approach, the 
center of the model, contains the traditional determinants of health: demographics, 
socioeconomic status, behavior and family. These factors have the most influence on a person’s 
health. In the next sphere of influence are more community based factors such as: The 
socioeconomic environment, health services, natural environment and built or manmade 
environment. The next level may include society in a broader sense. These factors include: 
agriculture and food, international trade and relations, religion, politics, policies, social norms, 
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culture and macroeconomics. The risk factors for chlamydia listed in the charts from left to right 
indicate highest to lowest risk. Each factor, combined with others, increases the risk for 
chlamydia and other STDs (Shi and Zhong, 2014).   
Demographic risk factors for chlamydia include age, gender, race and socio-economic 
levels as seen in Table 3.  The highest risk group is in the youngest age of sexually active youth, 
15-24 years old. The risk decreases as age increases. More research is needed to understand 
decreasing rates in those 25 and older. In the group over 40 years old the risk for chlamydia is 
the lowest. Women consistently have higher risk than men.  
The B/AA race has the highest rate of infection and Hispanic people are next highest, 
facing much higher risk than whites. The Asian race in America continues to experience the 
lowest level of risk.  
Education in years is inversely proportional to risk for chlamydia. Populations that have 
not graduated from high school are in the highest risk category. Those with associate degrees or  
 
Table 3 Risk Factors for Chlamydia Infection by Demographics 
 
Demographic Highest Risk High Risk Lower Risk Lowest 
Risk 
Age 15-24 25-29 30-40 Older 
Gender  Female Male   
Race 
 
Black/AA Hispanic Native Am. 
Indians  
Asian 
Education Less than high school 
graduate 
Associates degree 
or trade 
4 yr college Advanced  
Degree 
 
Socio-economic 
group 
Annual income 
poverty or below 
Low to Moderate 
income 
Higher levels of 
income 
High 
Income 
 
Note from National Survey of Sexual Health and Behavior, 2010, BRFSS, 2007 
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trade school certification have less risk while people with four year or advance degrees are in the 
lowest risk group. Education not only increases knowledge about diseases, healthy sexual 
behaviors, and birth control, those with higher education usually have higher levels of income. 
Health indicators have shown to be directly related to education levels (Baum and Payea, 
2005). In one study of education levels, the death rate in those 25-64 years old and with 
education beyond high school was 206/100,000. In the group with only a high school education 
the death rate was 478/100,000 and in the group with less than a high school education the death 
rate increased to 650/100,000 (Woolf, 2005). 
Higher levels of education result in better paying jobs. As seen in Table 4, the benefits of 
better jobs affect the risk levels for chlamydia as presented in 2005 by the College Board (Baum 
and Payea, 2005). Teenage children, whose parents have high incomes, have extra money for 
spending on luxuries such as fashionable clothes, games, parties and after school activities. There 
is more money for family recreation and time with one or both parents, promoting close 
relationships through for sharing, support and encouragement. Healthy relationships within 
families discourage premature intimacy involving sex. Adolescents with good self-esteem, 
established by loving families do not need to abuse drugs and alcohol for peer acceptance or to 
escape emotional stress. Their parents model better coping skills. The young people receive 
regular healthcare and do not have extreme anxiety about seeking care when they are sick. 
Families of college graduates experience fewer divorces. Single parents struggle to meet the 
financial and emotional needs of their children and themselves. Higher income families tend to 
live in less populated areas where violent crime rates are also lower. 
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Table 4 Benefits of Education in Regard to Risk for Chlamydia 
Outcome of Higher 
Education 
 
Benefits that Reduce the risk of Chlamydia 
 
Higher Income 
Luxuries: Clothing, entertainment, and activities with friends 
Family time: Recreation, stress reduction, support 
 
 
Better Parenting 
Lower divorce rate 
Easier to meet the financial and emotional needs of children 
More time to be involved with learning 
 
Healthy Behaviors 
Healthy relationships without drugs or premature sex 
Recognize unhappy, angry, violent and coercive behaviors 
Regular healthcare and healthy habits like diet and exercise 
Home in less 
densely populated 
area 
Lower violent crime rates: larceny, assault, rape, murder 
Neighbors are similar in supervision of youth, wholesome lifestyles 
with age level appropriate responsibility 
Note from College Board 2005 
 
As seen in Table 5, along with being free from disease, being health conscious is a 
personal choice. Good hygiene and regular healthcare reduces the risk of infections, including 
chlamydia. Conversely, poor hygiene and little or no healthcare are high risk behaviors. The age 
of sexual début is inversely proportional to the risk for chlamydia. Young people, 13 years or 
less, are more likely to be infected than people waiting until their 20’s before engaging in sex. 
The number of sexual partners in a year is directly proportional to the risk for chlamydia 
infections. People with four or more partners are at a greater risk than those with two or three. 
The least risk is encountered with one or less sexual partners.  
Sexual orientation is also a risk determinant. Homosexuals have the highest risk. 
Heterosexual individuals are at the lowest risk whereas bisexual people have a moderate risk of 
chlamydia infection. Sexual ethics are often linked with religious attitudes. Adolescents that 
consider sex an education or a fun adventure are at the highest risk for STD. On the opposite end 
of the spectrum, a religious person that considers sex a sacred rite of passage into marriage has at 
a much lower risk of infection from chlamydia. 
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Table 5 Chlamydia Risk Factors Personal Behavior Choices  
 
Risk Factor 
 
Highest Risk 
Moderate 
Risk 
 
Low Risk 
Age of Sexual Début (vaginal 
intercourse)  
 
13 or less 
 
14-16 
 
17-25 
 
Health Consciousness 
Poor 
 hygiene 
 
Rare medical 
care 
Good hygiene, protect  
against disease and 
 regular medical care 
 
Number of Sexual Partners / year 
 
4 or more 
 
2-3 
 
1 or less 
 
Sexual Orientation 
Homosexual-
often high risk 
behavior 
Bi-sexual Heterosexual 
Sexual ethics and Religious attitudes Sex with 
various 
partners is an 
education, an 
adventure. 
People want 
experience 
before they 
think about 
marriage or 
children,  
A person’s body is a 
sacred responsibility to be 
respected. Having 
children is a gift after 
marriage. 
 
Note from National Survey of Sexual Health and Behavior, 2010, BRFSS, 2007 
 
Although the social environment or peer norms are less influential on many behaviors, it 
is one of the strongest risk factors for sexual behaviors and chlamydia infections (McLeroy, 
1988). Several examples of social norms and their influence on risk are presented in Table 6. The 
highest risk group frequently has unprotected sex. The sexually active group with moderate 
levels of risk may use condoms but sex may include brutality and cutting with exposure to blood. 
The lowest risk group has sex less frequently or they may abstain but they use condoms and do 
not engage in rough sex.  
Women in the highest risk group consider pregnancy acceptable and often desirable. 
They have the misconception that pregnancy can protect them from diseases. They may believe 
that being pregnant will endear them to the father or that being pregnant indicates maturity. They 
may also believe that government programs providing financial aid for pregnant women and 
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young children will improve their life. In the lowest risk group, women know that they need to 
protect themselves and their baby from STD. 
 
Table 6 Chlamydia Risk Factors Peer Group Behavior Choices 
 
Note from National Survey of Sexual Health and Behavior, 2010, BRFSS, 2007 
 
Whether or not healthy sexual behaviors are included in the school curriculum, the 
amount of education and open discussion concerning sex, sexual diseases and pregnancy 
prevention is inversely proportional to the risk for chlamydia. Adolescents that are ignorant in 
regard to sex are at the highest risk for contracting the disease. Those that are informed and 
expect partners to disclose diseases, especially HIV, are at less risk. However, the lowest risk is 
Risk Factor Highest Risk Moderate Risk Low Risk 
 
Sexual frequency 
with high risk 
partners 
 
Frequent 
unprotected sexual 
activities. 
 
Unprotected sex may 
use condoms, 
frequently with 
violence. 
 
Less frequency with 
condoms as a rule. 
No rough play with 
sex. 
 
Pregnancy and 
condom use 
Pregnancy offers 
protection from 
infections, lots of 
attention and 
financial benefits.  
Only use condoms 
during ovulation 
Pregnant women 
need to protect 
themselves and the 
baby from STD 
 
Education including 
information about 
sexual health, 
disease and birth 
control.  
No sexual  
education 
Discuss sex and 
issues with friends.  
Partner notification is 
expected, especially 
with HIV. 
Informed and a 
trusted counselor 
available 
 
Use of drugs, 
including alcohol 
 
A fix at any price, 
even violence. 
 
Getting high with sex 
enhances the 
experience. 
 
A little helps people 
relax, might forget 
the condom. 
Immune status Frequently 
symptomatic and 
diagnosed infected. 
Aware that some STD 
may attract other 
STD.  
Rarely sick and try to 
avoid people who 
don’t look well. 
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within groups that are comfortable talking about their sexually and have access to a trusted 
counselor for additional discussion or advice.   
In populations that use drugs, including alcohol, the highest risk is associated with the 
most intense addictions; sex or violence may be the price for the drugs they need. For people 
using drugs to enhance their sexual experience, the risk for chlamydia infections is moderate. 
The lowest risk factor for drug users is found among those who are using to disconnect or just 
relax. Immunity is directly proportional to risk for chlamydia if other factors are equal. People 
that are frequently sick are at a higher risk for STI than those who are rarely sick and able to 
mount an immune response if exposed to pathogens. Additionally, poor health habits such as 
inconsistent sleep, poor diet, stress, substance abuse and overworking contribute to lower 
immunity. 
Subpopulations with Specific Risk Factors 
Specific subpopulations warrant culturally specific interventions such as American Indian 
natives who have unique and predisposing risk factors, such as ethnic isolation, poverty, 
discrimination, and genetic tendencies for alcoholism, depression and suicide (Missionaries of 
Sacred Heart.org, 2014). For example, young Indians would be more receptive to discussions 
about their private sexual behaviors with another Indian that grew up in the same community, 
who can speak in their language and understand that alcohol dependence can be a major issue in 
their family or personal life. 
Another specific risk factor in the sub-population of MSM is multiple infections in 
different anatomical sites. Data retrieved from the 2007 Behavior Risk Factor Surveillance 
Survey (BRFSS) from six metropolitan areas around the country revealed 1600 positive cases 
(5.3%) for chlamydia from 30,000 MSM study participants.  Of the pharyngeal and rectal 
22 
 
samples from the same study, 9% and 5 % were positive respectively (MMWR, 2009). The 
positivity of nearly 20% genital samples in this cohort further emphasizes the crucial need to 
screen high risk men for chlamydia.  More than one anatomical site may be infected if MSM are 
HIV positive and participate in oral or receptive anal intercourse (Carpenter, 2013). 
Two additional MSM sub-populations have specific risk factors, those incarcerated and 
among the homeless (Stein, 2013) (Brewer, 2012). The number of self-reported MSM is 
increasing as the social stigma of homosexuality is declining.  STI among MSM incarcerated are 
also increasing. In a 2012 report to the XIX International AIDS Conference researchers found 
“an extremely high prevalence (60%) of incarceration history among black MSM (BMSM) 
enrolled in the HIV study, highlighting incarceration as an important public health issue among 
BMSM" (Brewer, 2012). In another study of HIV positive inmates in ten jail sites, 22 % of black 
male participants self-identified as MSM (Stein, 2013). The comorbidity of chlamydia and HIV 
positive males emphasizes the risk factor of incarceration and the need for chlamydia screening 
(Nelson, 2008). Chesson and Pinkerton have demonstrated the positive economics of screening 
MSM for chlamydia among those at high risk also for HIV in a 2000 study. 
Homeless populations, specifically youth among the homeless, face additional health 
risks such as drug abuse, mental illness and sexually transmitted diseases. The estimated national 
prevalence of youth experiencing homelessness in 2007 was 1.6 million. “In 2007, the National 
Alliance to End Homelessness analyzed 17 research studies to estimate that 20% of youth who 
are homeless identify as lesbian, gay, bisexual, or transgender (LGBT.)”  Substance Abuse and 
Mental Health Services Administration (SAMHSA) also reported more than 50% of the 
homeless surveyed were B/AA and more than 70% were male (SAMHSA, 2007).  There is 
growing concern regarding health issues such as methicillin resistant Staph and HIV in this 
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population. There needs to be concern regarding chlamydia as well. Sexually active young adults 
and MSM must be made aware of the consequences of untreated chlamydia and the benefits of 
being tested.  
High risk sexual behaviors include limited sexual education, reluctance to use condoms 
and an acceptance of multiple and casual sex partners. Additional environmental factors may 
include substance abuse and high crime rates such as domestic violence, rape, and prostitution.  
Pockets of higher concentration of infection in sub-populations suggest multiple high risk 
behaviors leading to high incidence and reinfection rates. “Not all factors are equal in their 
potential to be changed. Some can be changed by personal determination; others require policy 
and economic reform” (Shi and Zhong, 2014). As illustrated by the Shi and Zhong System of 
Health Model in Figure 2 public health policies are demonstrations of power distribution 
incorporated by the WHO in 2011. Policies have strong influence over individual behaviors.
  
Note from Current Opinions in Biotechnology, 2014 
Figure 2 
 System Model of Health 
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Comparison of 10 High Chlamydia Incidence States’ Public Health Policies  
Partner management is crucial for control of sexually transmitted diseases and state 
public health policies determine the method employed. Face-to-face investigation and 
notification of exposure of sex partners by public health professionals is the most effective 
method of ensuring appropriate partner management. However, resources rarely permit such 
intensive actions for numerous gonorrhea and chlamydial infections (Hogben, 2006). One state 
public health policy that has been implemented to combat chlamydia is Expedited Partner 
Treatment (EPT.)  EPT programs attempt to break reinfection cycles by sending antibiotics home 
with the index patient for the treatment of their sex partner without a clinical assessment. EPT 
effectiveness results vary from 48% to 79% being notified and 30%-61% being treated 
particularly if accompanied by information about the infection, risks, along with the rational and 
instructions for treatment (Hobson, 2008). Due to the efficacy and economics of EPT, 44 states 
have legally approved this method. The six states that do not allow this type of partner 
management are Florida, Kentucky, Michigan, Ohio, Oklahoma and West Virginia (CDC, 2013). 
Their medical boards have liability concerns regarding malpractice in the treatment of patients 
without a clinical assessment. Participating states have incorporated language protecting 
physicians and healthcare extenders from slander, breach of privileged communication of health 
information and partner injury from antibiotics prescribed for the treatment of gonorrhea or 
chlamydia. The risk of adverse drug reactions are minimized by counseling and written materials 
describing potential allergic responses, side effects, and danger to pregnant women.  
To evaluate the use of EPT and sexual education in school plus other sexual behaviors 
indicators and risk factors, a cohort of states was selected using CDC 2009 statistics of the 
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highest chlamydia incidence in the US.  In Table 7 incidence is sorted from the highest to the 
lowest as follows: Mississippi, South Carolina, Louisiana, North Carolina, Texas, Michigan, 
Ohio, Indiana, Florida and Pennsylvania. The table has the following fields: Expedited Partner 
Treatment (EPT) allowed, percent sexually active young people ages 15-24 years, percent 
consistently using condoms, teenage pregnancy rates and whether school sexual education 
programs were required. 
 
Table 7 States with Highest Chlamydia Incidence and Associated Policies, Sexual Behaviors and 
Rates, 2011 
 
 
State 
 
Chlamydia 
Rate* 
 
HIV 
 
EPT 
 
School Sex 
Education 
 
Sexually 
Active 
Teens 
 
Condom 
Use 
 
Teen 
Pregnancy 
Rate** 
 
MS 
 
1029 
 
310 
 
Yes 
 
Required 
 
60% 
 
67% 
 
60 
 
LA 
 
1011 
 
310 
 
Yes 
 
No 
 
*** 
 
*** 
 
52 
 
SC 
 
937 
 
239 
 
Yes 
 
Required 
 
52% 
 
62% 
 
45 
 
NC 
 
879 
 
276 
 
Yes 
 
Required 
 
52% 
 
62% 
 
42 
 
TX 
 
752 
 
313 
 
Yes 
 
Required 
 
63% 
 
56% 
 
58 
 
MI 
 
722 
 
152 
 
No 
 
Required 
 
42% 
 
65% 
 
33 
 
OH 
 
659 
 
161 
 
No 
 
Required 
 
44% 
 
60% 
 
38 
 
IN 
 
609 
 
439 
 
Yes 
No, HIV 
only 
 
50% 
 
58% 
 
41 
 
FL 
 
564 
 
537 
 
No 
 
Required 
 
50% 
 
66% 
 
35 
 
PA 
 
560 
 
102 
 
Yes 
 
Required 
 
48% 
 
65% 
 
29 
Note from CDC/STD/stats2011, BRFSS, 2010                              
* Rate per 100,000 
**Rate per 1000 
***Data not available  
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The five states in the cohort with the highest reported chlamydia infections were 
Mississippi, South Carolina, Louisiana, North Carolina and Texas.  The five states with the 
highest incidence allow the EPT form of partner treatment. Additional studies may determine the 
fidelity of EPT programs implementation and maintenance.   
High rates of HIV and teenage pregnancy were parallel with high chlamydia rates. Five 
states that reported HIV incidence rates greater than 300/100,000:  MS, LA, TX, IN and FL.   
Other cohort observations from Table 7: 
 
 Six states in this sample also reported teenage pregnancy rates greater than 40/1000: MS, 
LA, SC, NC, TX and IN.  National average is 31/1000. 
 The behavior ‘early sexual activity’ for teenagers in most states was reported to be 46- 
56% active.   
 Most states reported 55-65% condom  use in the 15-24 year age group.   
 Eighty percent of the states require sexual education classes.  
State specific observations from Table 7: 
 Louisiana and Indiana were two states not requiring sexual education in the school 
curriculum and had high rates of chlamydia or HIV.  
 Texas had the highest percent of sexually active teens and the second highest rate of teen 
pregnancy and the fifth highest chlamydia rate. 
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 Mississippi had the highest rate of chlamydia, sexually active teens, condom use and teen 
pregnancy despite a sexual education policy. But Mississippi’s HIV rate (310) is very 
close to Louisiana (310) and Texas (313.)  
 Florida has nearly the lowest chlamydia rate in the cohort along with low teen pregnancy 
and high condom use but they do not allow EPT and has the highest HIV rate (537) in 
this group of states.  
 Indiana has relatively low teen pregnancy rate (41) but above the national chlamydia rate 
and the second highest HIV rate in the cohort. Indiana’s state policy is to educate youth 
only about HIV in sexual health programs.  
 North Carolina ranked among the highest in the cohort for significant risk factors.  NC 
had the sixth highest rate of HIV, fifth highest teenage pregnancy rate and the third 
highest sexually active teens 15-19 years old.  
In summary, the comparison of state public health policies within a peer group of states, based 
on high rates of chlamydia infection, interventions such as EPT, sexual education in schools and 
condom use in NC were similar to others in the study group. Despite these efforts rates continue 
to climb.  
DATA ANALYSIS 
 
Chlamydia epidemiology begins with an accurate count of cases, age, race and gender. 
The age group of highest incidence of chlamydia was among the 15-24 age groups, all races and 
both sexes. True incidence among gender and racial lines was blurred by availability of 
screening and confirmation tests in addition to reluctance for testing due to social factors like 
religion, sexual orientation stigma and lack of community awareness and as policy and program 
decisions to support chlamydia screening (McLeroy, 1988) 
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Under testing men skews chlamydia incidence distribution ratios between the sexes. 
Reported positive tests from women outnumbered positive cases reported from men on average 
four to one (CDC, STD/stats09). Unless limited by specific environmental requirements, an 
obligate parasite transmitted primarily by sexual contact could be more evenly distributed 
between the sexes than data supports, MSM populations excluded. Statistics in Table 2 of the US 
data emphasized the difference in gender ratios when traditionally women are diagnosed with 
chlamydia and then confirmed.  From 2006 to 2010 the rate in men increased 36% compared to a 
20% increase in women during the same period (CDC, 2010).  Some of the male-female variance 
may have improved with the use of nucleic amplification test methodology by accepting urine 
samples, more receptive for men. 
Conversely, the EPT approach to partner management is another unfortunate factor in the 
under reporting of male chlamydia infections. Without positive case confirmation, male partners 
are treated and not reported to CDC.  
Success stories 
Two sexual behaviors that have been positively influenced by community awareness and 
education are the acceptance of the human papilloma virus (HPV) vaccine and teenage 
pregnancy. Since the HPV vaccine was introduced in 2006, the prevalence in girls 14-19 years 
old has decreased 56% (Sow, 2013). The controversy about the vaccine raised by parents stems 
from the reluctance to accept the high incidence of a sexually transmitted disease in young girls. 
Some parents are resisting protecting their daughters from HPV and its sequellae with the 
misconceptions that their children will not engage in sexual activity, or they do not believe their 
young lady will be infected and  fall victim to cervical cancer. Although only one third of young 
girls have received the vaccine, it is estimated that 25,000 cervical cancers have been prevented. 
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The social context of HPV is similar to the resistance towards chlamydia screening. Chlamydia 
interventions require public awareness campaigns similar to HPV and community activation to 
bolster acceptance.  
 Another public health success story is the battle against unwanted teenage pregnancy. 
Teen pregnancy has been the subject of countless public awareness campaigns in the last two 
decades. As a result rates have consistently declined 42% from 62/1000 among 15-19 year olds 
in 1991 to 29/1000 in 2012 (DHHS, 2012). Rates for minorities are double those for whites. In 
1991 the teen rate for B/AA was 117/1000. In 2012 rates dropped to 44/1000, slightly below the 
Hispanic rate of 46/1000. The success of teenage pregnancy prevention is credited to teens 
delaying sexual activity until they are older and improved use of contraception (Santelli, 2007).  
Research led to positive actions taken at the state level in Georgia, California, Tennessee, 
New Mexico and Texas. These pioneer efforts offer guidance for collaboration within the 
legislature and outside organizations plus policies to combat chlamydia in the high incidence 
states. 
State Senator Jan Orrock of Georgia sponsored the 1998 Chlamydia Screening Act, 
HB1565, requiring health insurers to cover annual screening for women under 30 years old by 
presenting evidence that chlamydia screening would save money and improve health across the 
state. Collaborating with the Women’s Caucus, Health Committee, Appropriations Committee 
and the House Public Health Officials and the State Medicaid agency built support for the bill 
and reimbursement to physicians for treatment (CDC, 2013). 
Fifteen years ago California formed the California Chlamydia Action Coalition (CCAC) 
with the State STD Control Branch, the California HealthCare Foundation and the University of 
California at San Francisco. With this public-private cooperation State Senator Deborah Oritz 
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sponsored the first EPT bill, SB648, allowing healthcare workers to dispense antibiotics for the 
sex partners of persons infected with chlamydia. A toolbox was developed with an informational 
flyer and support was offered on site to train physicians. They also established a chlamydia data 
base for accession by managed care organizations and public health agencies (CDC, 2013).  
In 2000 California launched a multidimensional public health intervention program to 
control chlamydia. California STD Control Branch together with other public health leaders built 
support to form the California Chlamydia Action Coalition (CCAC.) Stakeholders from public 
and private sectors initiated activities including screening, partner services, awareness campaigns 
and tracking (CDC, 2013). 
For more than a decade Tennessee has been taking steps to reduce chlamydia incidence. 
The Department of Health in Tennessee worked with the managed care organizations that 
provided services for the state’s Medicaid populations to add annual screening for chlamydia as a 
quality of care measurement for sexually active women 15-24 years old. Testing was also 
expanded by screening all requesting pregnancy tests in state family planning clinics. In 2002 
EPT was implemented by the Board of Medical Examiners. In 2006 Knox County received a 
Department of Health grant to screen all juveniles in the detention center by way of urine 
samples (CDC, 2013). 
In 2007 New Mexico’s Public Health Department and the State Medical Society joined to 
form the Clinical Prevention Initiative to help implement evidence based interventions based on 
US Preventative Services Task Force recommendations. Collaborative organizations included 
managed care organizations and the American Cancer Society. Efforts focused on chlamydia 
screening women 25 and younger, men and women that are sexually active with more than one 
partner or have been recently diagnosed with an STD regardless of age and all pregnant women. 
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Handouts were developed with information regarding symptoms and the risks involved with 
infection. Letters were sent to healthcare providers to train and inform the reasoning behind new 
test guidelines, recommended treatment and reimbursement rates. The improvements in 
screening were geared to the private and public sectors. When funding becomes available, their 
next steps include screening in schools and correctional facilities (CDC, 2013). 
Texas Department of State Health Services received the National Public Health 
Information Coalition’s Bronze Award for excellence in Public Health Communications for a 
media campaign to increase STD awareness and the need for testing among B/AA women 15-19 
years old. Television, radio, billboards were used and the CDCynergy disc for healthcare 
providers guidance. A follow up survey indicated 28% of participants discussed STDs with 
someone and 19% sought testing because of the ads (CDC, 2013). 
 
Limitations to Current System of Data Collection 
 Prevalence determination was biased by asymptomatic cases, data missing from men who 
are not tested and cases from reinfection that may have been recorded as more than one 
person.  
 Statistics compiled for annual reports are 1-5 years behind the current year.  
 Intervention programs are often community driven therefore their actions were not 
available as state policies. 
 Evaluation studies to assess factors contributing to high chlamydia rates were not 
conducted and are not available. 
 
RECOMMENDATIONS 
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The vital action that will reduce the number of infections in N.C and the U.S. is 
expanding screening for chlamydia (USPSTF, 2007) (Guy, 2010).  ). The target racial/ ethnical 
subpopulations with highest chlamydia incidence are B/AA and Hispanic minorities and MSM. 
Sexually active men and women in the high risk categories, regardless of symptoms, are among 
those recommended to be tested annually until age 26, in the first and last trimester of pregnancy 
and with a change in partners (CDC, 2011). To provide at least minimum care, screening in high 
risk minorities will provide prompt treatment and simultaneously improve prevention of new 
cases and reinfections within a sexually active network. After testing positive, it is recommended 
that the index person  be retested in 3-6 months to ensure the drugs worked or the person has not 
be exposed to a new case.  Reinfection rates should be measured for three to four years (Puget 
Sound, 1997, CDC Grand Rounds 2011).   
With confirmed chlamydia infections, effective partner management decreases 
reinfection rates. Sexual monogamy in teenagers and young adults in the high incidence groups 
is no longer a reliable standard by which partners may be treated for chlamydia. Treatment via 
EPT may need to provide for multiple partners. Men and woman may be exposed from sexual 
partners, men or women, and they may be a source of infection to men or women.  States that 
fund screening for male and female patients in STD clinics show common sense and 
commitment to containing the epidemic. This would require a modification of the current testing 
policy and legislation to fund the additional screening. 
Ms. Chan, President-elect, addressing the WHO Board in January 2012 emphasized the 
key to breaking cycles of poor health. Diseases such as chlamydia will need to be addressed as if 
they were chronic conditions (CDC, MMWR, 2012).  In the 2011 CDC Disparity and Inequities 
Report persistent gaps are highlighted between the healthiest Americans and the least healthy. 
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“Although encouraging…interventions to be applied universally, are seldom sufficient to address 
the problems effectively.” (CDC Grand Rounds, 2011) The disparities between whites and 
minorities regarding sexually transmitted diseases are affected by an integrated array of factors: 
education, geography, culture, religion, urban or rural living and mental health.  
Combatting the chlamydia requires complex long range planning of social interventions 
aimed at determinants of health, promoting healthy sex behaviors among youth and activating 
community awareness about the benefits of screening. A model of the determinants of health by 
Evans and Stoddart shows how risk factors at the biological level, environmental level and 
individual responses interact to disease and/ or well-being (Evans and Stoddart, 1990). 
Recommendations for interventions fall under the top categories of social, physical, and genetic. 
Social networks or peer groups have the most influence on sexual behavior, therefore promoting 
healthy attitudes and behaviors through the media, peer mentors, or community leaders is a 
priority. Education also falls under social interventions. Education usually improves the quality 
of health, healthcare, overall well-being and healthy development of children. Sexual education 
encourages young people to make informed decisions about sex and birth control. Empowerment 
is another health determinant as well. In other broad categories of this model, an individual may 
have less personal control but the information is beneficial to those determined to improve their 
circumstances. For example eating a healthy and well balanced diet bolsters the body’s ability to 
fight disease. Living in crowded conditions is more stressful than in a more spacious 
environment. However it may be possible for adults to choose to avoid toxins at work or around 
their home. Genetic predispositions may not be avoided but one can be aware of family traits 
such as alcoholism or mental illness so that appropriate help can be sought when needed. 
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Community leaders should be presented with proof positive evidence from other 
communities or states that disease prevention in the form of vaccines or screening tests does not 
encourage promiscuous sexual activity and that chlamydia screening is cost effective. In 2007 
the estimated cost of chlamydia infections, including associated infertility was over 700 million 
dollars (USPSTF, 2007).  A cost analysis of preventative screening can be compared to such 
staggering figures. Private insurance companies are starting to see the cost benefit of screening 
also; some like Blue Cross/ Blue Shield NC are providing coverage for chlamydia screening 
(BlCrBShNC.org, 2014)  
Legislators undoubtedly aware of enormous healthcare costs being diverted to 
government programs have a responsibility to become aware of the cost benefits and promote 
chlamydia screening in government subsidized settings. According to the National Committee 
for Quality Assurance only 57% of the Medicaid population has been tested; intense focus is 
needed to increase chlamydia screening (2010). Public education and reduction in disease 
incidence and sequellae will influence political support and funding. Alternatively, funding for 
additional testing can be diverted from long term illnesses like HIV and Hepatitis B as incidence 
rates decrease in this population. 
The long term benefits of combatting chlamydia are cost effective and responsible 
healthcare. Resources allocated for prevention serve to contain long term costs. Local legislators 
may be motivated to support additional screening realizing they are in line with the Affordable 
Care Act.  In conjunction, new CDC funding was announced in March, 2014 for a Community 
Approach to Reduce STD (CARS) (CDC, 2014). Healthy People 2020 goals  for population 
health result in people with higher levels of prosperity, able to contribute more to society, urban 
development and government infrastructure while protecting others from health robbing 
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diseases. Chlamydia screening is in line with the national ‘Dollar 1 Prevention’ priorities 
(USPSTF, 2007). As chlamydia containment programs are implemented, quality measures and 
assessments will provide additional evidence based practices for future programs. North Carolina 
can serve as a model for other high incidence states by focusing cost effective interventions on 
those at greatest risk that can be scaled up within the existing public health infrastructure 
(Golden, 2005).  
Legislative support is overdue to gain control of the US chlamydia epidemic. States need 
specific STD testing policies regarding chlamydia screening. Policies for testing men in STD 
clinics, HIV treatment centers and general practices ensure rapid treatment and reduce 
reinfections. The disproportionate rise in the number of positive men compared to positive 
women may become more balanced in the future if male screening continues to be emphasized 
and sampling is more acceptable.  
States continuing partner management with treatment programs like EPT help prevent 
further transmission and reinfections. Effectively disseminating information about birth control, 
sexually transmitted diseases and safe sex behaviors in basic sexual education curricula 
decreases infection rates. Abstinence education has not been proven effective for prevention of 
risky sexually behavior among youth and is not recommended as an intervention for chlamydia. 
Such issues raise public debate but also stimulate public involvement and awareness of STI. 
MSM is continuing to grow as a target population. Screening for chlamydia among those 
incarcerated would provide more accurate male incidence data. However, as in the concluding 
remarks from an Australian study state, “There is poor adherence to national guidelines that 
recommend re-testing of MSM for STIs, particularly among those at higher risk who …(would 
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benefit from) more frequent testing. Clinical strategies are urgently needed to encourage more 
frequent testing…, especially in the higher risk subgroup.” (Guy, 2010).   
Screening young people presents specific obstacles to overcome. Education regarding 
safe sexual behaviors and diseases presented on the internet or social media formats like Face 
Book and Twitter has shown to be preferable and effective with today’s youth (Jones, 2012.) The 
Canadian program “Get Tested, Why Not” resulted in 13,000 website hits within one year 
(Mann, 2013). Another public outreach campaign successfully used television advertising for a 
telephone hotline to access pre-recorded “Check It Out” chlamydia information and care seeking 
(Oh, 2002).  
Funding is needed to improve access for younger people to be tested and treated without 
parental consent. Teens in the 12-17 year old range typically have limited transportation, 
employment, and personal health insurance. Web-based surveys like “The Unzipped Trial” in the 
UK overcame transportation and access obstacles and offer free chlamydia testing (Nicholas, 
2013). The cost of increased screening is only one obstacle; preventing infections relies on 
healthy sexual behaviors. In the Motivating Adolescents to Reduce Sexual Risks (MARS) study, 
young people became aware of the cost of disease detection in relation to the cost of treatment. 
Then they became more motivated to reduce high risk behaviors. This economic approach was 
tested in 14-18 year olds who learned that one dollar spent on prevention of bacterial STD saved 
two dollars over treatment (Dealy, 2013)  
The traditional clinic setting for screening presents more challenges for teens. Concerns 
about clinical exams include being emotionally uncomfortable and experiencing physical pain. 
Clinics offer confidentially in regard to testing and results but teens have been confronted by 
parents when billing and insurance claims are sent home. New test methods make self and home 
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sampling of urine or low vaginal swabs more acceptable than sampling requiring clinical exams.  
Noninvasive, self-sampling further increases the receptivity of young people to submit to 
screening plus reduces the overall cost of the procedure by eliminating the personnel time and 
overhead in a clinic. To eliminate patient and sample transportation barriers, samples could be 
collected outside the clinical setting, such as in-home, outreach events or through school health 
programs. This would be a tremendous advantage for the 13-18 year age group where parental 
involvement and peer stigmatism can be avoided. Mail-in samples have been incorporated into 
studies with success (Nicholas, 2013). 
States websites were searched for chlamydia intervention programs that included 
behavior and community involvement interventions. At the time of this research, none of the 
high incidence cohort had strong chlamydia specific programs. However, Indiana’s HIV 
Capacity Building Assistance Program was outstanding and has potential as a model for 
chlamydia interventions.  Guidelines for the program were modified from the Community 
Planning Guide for HIV Prevention from CDC (2003). Interventions included healthy behavior 
education, prioritized actions in the critical target populations, routine follow up testing and 
community collaboration. The Indiana program also contained key components to increase 
prevention of HIV and other STDs while improving community intervention infrastructure.   
Indiana acknowledged chlamydia was a health concern among the HIV high risk populations. 
“Chlamydia, usually an acute disease, has reached the characteristics of a chronic infection with 
population prevalence patterns in some parts of the nation.  Reducing the number of infections 
and re-infections in these subgroup populations will depend on chronic disease interventions 
with healthy sexual behaviors at the foundation” (www.Indiana.gov, 2012). 
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 Public health policies for additional chlamydia screening have been limited by strong 
opposition to invasion of privacy and self-determination in this country. Advocates for disease 
prevention are required to balance benefits for the public domain with individual rights of 
personal freedom. Economic impact for healthcare was not a deciding factor in legislation for 
prevention until public health insurance like Medicaid, Medicare and new national subsidies 
became the predominant source of US healthcare funding. Government pocketbooks will not be 
able to sustain the growing demand for debilitating chronic health conditions and exorbitantly 
expensive acute diseases like HIV. The funding for additional screening for chlamydia was not 
allocated in the past due to competition with other public health programs. However, with 
increased research implicating the co-morbidity of chlamydia and HIV the economic impact is 
more urgent. With millions of chlamydia infections the disease burden is also more significant. 
Local and state governments can implement measures for mitigating these concerns. 
Four examples of state chlamydia programs were found outside the cohort of high 
incidence, Georgia, California, Tennessee and New Mexico. Several relied on legislation to 
enforce compliance and demonstrate collaboration between public health, the medical 
community, insurance and Medicaid providers. Private physicians were trained and media 
campaigns disseminated information about chlamydia and screening. 
As a nation healthcare is moving towards managed care and as it does an opportunity is 
presented to change attitudes and include chlamydia screening during general practice visits. 
Young people have a higher degree of confidence in their familiar family physician than 
clinicians in a clinic and prefer being offered the testing in the general practice environment 
(McNutly, 2013). In a capitated system, physicians will be more motivated to maintain health 
and promote prevention. Leverage may also be applied to insurance providers to require annual 
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screening and cover the costs. Abundant opportunity lies in the previously uninsured populations 
enrolled in the new Obama’s Affordable HealthCare program. 
 
 
 
Obstacles and Global Lessons to Apply to the Future 
Chlamydia is a chronic health issue in many countries around the globe. England, 
Australia, Peru, Thailand, the Netherlands, Norway and several African nations are  
implementing chlamydia control programs. Further research as to the successful components and 
obstacles encountered would be of benefit as new programs develop. A few challenges covered 
in this paper are applicable now in the US and others may be more acceptable in future efforts to 
curb chlamydia and other STIs.  
Social context and behaviors are the most complex intervention challenges. However, at 
this time community based awareness of the benefits of chlamydia screening may be the most 
powerful tool for states like North Carolina. To create interventions for specific social settings, 
public health will need to work within communities to influence individuals to change unsafe 
behaviors.  Collaboration between private and public healthcare providers with other 
organizations such as schools, faith based groups, and industry will multiply the efficacy of 
health promotion and share limited resources. 
Just as communities and individuals must adjust their attitudes about sexual health, 
general practice physicians must also become informed about chlamydia and convinced in the 
effectiveness of screening. Some practices in England found that computer reminders were 
helpful for new screening protocols (McNutly, 2013).  Financial incentives for physicians have 
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strongly influenced physician’s personal attitudes but do not sustain increased chlamydia 
screening if long term attitudes are not influence by other interventions (Turner, 2011). A review 
of various interventions to increase testing in British primary care offices found that providing a 
urine container at the reception area and “universally offering a test for chlamydia had the 
greatest impact, increasing screening to 44% compared to 16% in control practices” (McNulty, 
2013)(Guy, 2011).  
 In the future greater access for chlamydia screening may include local pharmacies. In 
Perth, Australia an innovative program is called Emergency Contraception Mediated Pharmacy 
Access to Chlamydia Testing or EMPACT for customers. After consultation with the pharmacist 
asymptomatic men and women are offered a free test kit for home sampling. The samples are 
then mailed to be analyzed (Nicholas, 2013) (Gudka, 2013). 
 Another idea that could be considered in the future is for young ladies having combined 
chlamydia tests when PAP smears are performed. Fluid from the PAP samples of 4000 women 
was tested for chlamydia with two different amplification tests. The results were excellent for 
detecting chlamydia without additional confirmation testing (Martins, 2013). 
 In certain high density populations of HIV positive MSM structural interventions have 
shown to decrease STI. For example a study in Los Angeles County Men’s Central Jail MSM 
unit, condoms were distributed once a week to determine the reduction in HIV transmission and 
net social cost. Based on estimates from 2007 inmate survey and literature sources one in four 
new HIV infections were averted by this intervention (Leibowitz, 2012). Protective measures for 
STI like condom distribution are simple cost effective controls. 
 Future considerations may require more leeway in sampling, ingenuity for treatment 
options acceptable for target populations and frank dissemination of information in the 
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community about chlamydia infections. Some progress has been made toward a vaccine but 
behavioral interventions may be implemented before it becomes available. By continuing 
research in response to pathogens such as chlamydia, the human, social, and economic disease 
burdens arising from chronic conditions can be reduced.  
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